Company profile: Letoon
1.1 - Company Overview
Company description
- Provider of ultrasonic extraction technology to convert vegetable waste and plant matter into high-value nutrients and ingredients, including lycopene recovery from tomato waste, serving the pharmaceutical, nutraceutical, cosmetic, and food sectors. Activities include production of high-value commodities, mergers and acquisitions, and research partnerships with Italian universities.
Products and services
- Recovery of lycopene from tomato waste: Extracts lycopene, a powerful antioxidant, from tomato by-products for pharmaceutical and nutraceutical use through a tomato-waste-derived, dedicated process
- Ultrasonic extraction technology: Utilizes high-frequency sound waves to disrupt cellular structures in plant matrices, efficiently releasing bioactive compounds for conversion into high value added nutrients and ingredients
- Production of high-value commodities for pharmaceutical, cosmetic, and food industries: Produces value-added nutrients and ingredients from vegetable waste and botanical products for pharmaceutical, cosmetic, and food sectors using vegetable-waste-derived processes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Letoon
Vince & Associates
HQ: United States
Website
- Description: Provider of clinical research and cardiac safety services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vince & Associates company profile →
Quay Pharma
HQ: Australia
Website
- Description: Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quay Pharma company profile →
Pro-Spectus
HQ: United States
Website
- Description: Provider of healthcare advisory services specializing in the pharmaceutical, medical device, and diagnostic healthcare industries, offering a Patient Access Program that enables patient and market access to therapies by optimizing the patient access journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pro-Spectus company profile →
Xcenda
HQ: United States
Website
- Description: Provider of strategic consultancy and managed markets agency services delivering strategic insights, health economics and outcomes research (HEOR) expertise, and reimbursement support to global companies and emerging pre-commercialization phase firms, with 20+ years of real-world experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcenda company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Letoon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Letoon
2.2 - Growth funds investing in similar companies to Letoon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Letoon
4.2 - Public trading comparable groups for Letoon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →